SPRTN protease and checkpoint kinase 1 cross-activation loop safeguards DNA replication.


Journal

Nature communications
ISSN: 2041-1723
Titre abrégé: Nat Commun
Pays: England
ID NLM: 101528555

Informations de publication

Date de publication:
17 07 2019
Historique:
received: 03 05 2019
accepted: 21 06 2019
entrez: 19 7 2019
pubmed: 19 7 2019
medline: 24 12 2019
Statut: epublish

Résumé

The SPRTN metalloprotease is essential for DNA-protein crosslink (DPC) repair and DNA replication in vertebrate cells. Cells deficient in SPRTN protease exhibit DPC-induced replication stress and genome instability, manifesting as premature ageing and liver cancer. Here, we provide a body of evidence suggesting that SPRTN activates the ATR-CHK1 phosphorylation signalling cascade during physiological DNA replication by proteolysis-dependent eviction of CHK1 from replicative chromatin. During this process, SPRTN proteolyses the C-terminal/inhibitory part of CHK1, liberating N-terminal CHK1 kinase active fragments. Simultaneously, CHK1 full length and its N-terminal fragments phosphorylate SPRTN at the C-terminal regulatory domain, which stimulates SPRTN recruitment to chromatin to promote unperturbed DNA replication fork progression and DPC repair. Our data suggest that a SPRTN-CHK1 cross-activation loop plays a part in DNA replication and protection from DNA replication stress. Finally, our results with purified components of this pathway further support the proposed model of a SPRTN-CHK1 cross-activation loop.

Identifiants

pubmed: 31316063
doi: 10.1038/s41467-019-11095-y
pii: 10.1038/s41467-019-11095-y
pmc: PMC6637133
doi:

Substances chimiques

DNA-Binding Proteins 0
SPRTN protein, human 0
CHEK1 protein, human EC 2.7.11.1
Checkpoint Kinase 1 EC 2.7.11.1

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

3142

Subventions

Organisme : Medical Research Council
ID : MC_EX_MR/K022830/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_UU_00001/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/M016587/1
Pays : United Kingdom

Références

Mol Biol Cell. 2004 Apr;15(4):1680-9
pubmed: 14767054
Exp Cell Res. 2014 Nov 15;329(1):26-34
pubmed: 25257608
Curr Biol. 2017 Jan 9;27(1):R33-R35
pubmed: 28073021
Nat Cell Biol. 2006 Jan;8(1):37-45
pubmed: 16327781
Elife. 2016 Nov 17;5:
pubmed: 27852435
Cell. 2014 Jul 31;158(3):633-46
pubmed: 25083873
Nat Rev Mol Cell Biol. 2008 Apr;9(4):297-308
pubmed: 18285803
Cell Cycle. 2006 Jan;5(2):125-8
pubmed: 16357541
Nat Rev Mol Cell Biol. 2004 Oct;5(10):792-804
pubmed: 15459660
Cell. 2000 Mar 17;100(6):681-92
pubmed: 10761933
Nat Rev Mol Cell Biol. 2008 Aug;9(8):616-27
pubmed: 18594563
Curr Biol. 2016 Dec 19;26(24):3257-3268
pubmed: 27818175
J Biol Chem. 2016 Oct 14;291(42):21956-21962
pubmed: 27601467
Mol Cell. 2019 Feb 7;73(3):574-588.e7
pubmed: 30595436
Nucleic Acids Res. 2016 Dec 15;44(22):11033
pubmed: 27683222
Cancer Res. 2000 Apr 15;60(8):2108-12
pubmed: 10786669
Nat Cell Biol. 2016 Nov;18(11):1185-1195
pubmed: 27723720
Mol Cell. 2016 Nov 17;64(4):704-719
pubmed: 27871366
Science. 2018 Aug 24;361(6404):806-810
pubmed: 30139873
Genome Biol. 2011 Aug 18;12(8):R78
pubmed: 21851590
Nat Struct Mol Biol. 2012 Mar 04;19(4):417-23
pubmed: 22388737
Proc Natl Acad Sci U S A. 2009 Mar 3;106(9):3184-9
pubmed: 19221029
Nucleic Acids Res. 2017 May 5;45(8):4564-4576
pubmed: 28199696
Cold Spring Harb Perspect Biol. 2012 Oct 01;4(10):
pubmed: 22904560
Cell. 2017 Feb 9;168(4):644-656
pubmed: 28187286
Science. 2015 Nov 27;350(6264):1092-6
pubmed: 26472760
Philos Trans R Soc Lond B Biol Sci. 2011 Dec 27;366(1584):3554-61
pubmed: 22084382
Science. 2015 Nov 27;350(6264):1096-101
pubmed: 26472758
Cell. 2013 Nov 21;155(5):1088-103
pubmed: 24267891
Hum Mol Genet. 2016 Apr 15;25(8):1574-87
pubmed: 26908596
Genes Dev. 2000 Jun 15;14(12):1448-59
pubmed: 10859164
Proc Natl Acad Sci U S A. 2008 Dec 30;105(52):20752-7
pubmed: 19091954
Mol Cell Proteomics. 2011 Sep;10(9):M111.011015
pubmed: 21642640
Nat Rev Mol Cell Biol. 2015 Aug;16(8):455-60
pubmed: 26130008
DNA Repair (Amst). 2004 Aug-Sep;3(8-9):997-1007
pubmed: 15279786
Nat Rev Mol Cell Biol. 2010 Mar;11(3):208-19
pubmed: 20177396
Science. 2000 Jun 2;288(5471):1643-7
pubmed: 10834843
Nucleic Acids Res. 2013 May;41(9):e104
pubmed: 23519618
Int J Cancer. 2014 Mar 1;134(5):1013-23
pubmed: 23613359
Nat Rev Cancer. 2007 Nov;7(11):861-9
pubmed: 17943134
Oncogene. 2007 Dec 10;26(56):7773-9
pubmed: 18066090
Proc Natl Acad Sci U S A. 2010 Sep 14;107(37):16090-5
pubmed: 20805465
Curr Biol. 2006 Jan 24;16(2):150-9
pubmed: 16360315
Mol Cell Biol. 2006 Apr;26(8):3319-26
pubmed: 16581803
Sci Rep. 2016 Apr 15;6:24491
pubmed: 27080861
Chromosoma. 2017 Feb;126(1):17-32
pubmed: 27086594
Nat Cell Biol. 2016 Nov;18(11):1196-1207
pubmed: 27723717
Trends Biochem Sci. 2017 Jun;42(6):483-495
pubmed: 28416269
Biochem J. 2012 Apr 1;443(1):13-26
pubmed: 22417748
Cell. 2015 Dec 3;163(6):1515-26
pubmed: 26627737
Nat Rev Mol Cell Biol. 2008 Nov;9(11):910-6
pubmed: 18813291
Nat Genet. 2014 Nov;46(11):1239-44
pubmed: 25261934
Hum Mol Genet. 2010 May 1;19(9):1690-701
pubmed: 20123862
Oncogene. 2009 Jun 18;28(24):2314-23
pubmed: 19421147
Nat Commun. 2014 Dec 11;5:5744
pubmed: 25501849
Mol Cell. 2016 Nov 17;64(4):688-703
pubmed: 27871365
Nucleic Acids Res. 2017 Apr 7;45(6):3172-3188
pubmed: 28053116
Cancer Cell. 2003 Mar;3(3):247-58
pubmed: 12676583
FEBS Lett. 2012 Nov 16;586(22):3974-9
pubmed: 23068608
Annu Rev Pathol. 2015;10:425-48
pubmed: 25621662
Fly (Austin). 2016 Apr 2;10(2):91-100
pubmed: 27064297
J Biol Chem. 2000 Feb 25;275(8):5600-5
pubmed: 10681541
Nat Struct Mol Biol. 2016 Feb;23(2):103-9
pubmed: 26840898
Cell. 2008 Jan 25;132(2):221-32
pubmed: 18243098
Mol Cell Biol. 2005 May;25(9):3553-62
pubmed: 15831461
Acc Chem Res. 2015 Jun 16;48(6):1631-44
pubmed: 26032357
Nat Cell Biol. 2014 Jan;16(1):2-9
pubmed: 24366029
Nat Rev Clin Oncol. 2019 Feb;16(2):81-104
pubmed: 30356138
Annu Rev Biochem. 2004;73:39-85
pubmed: 15189136
Methods Mol Biol. 2015;1228:123-31
pubmed: 25311126

Auteurs

Swagata Halder (S)

Cancer Research UK and Medical Research Council Oxford Institute for Radiation Oncology, Department of Oncology, University of Oxford, Roosevelt Drive, Oxford, OX3 7DQ, UK.

Ignacio Torrecilla (I)

Cancer Research UK and Medical Research Council Oxford Institute for Radiation Oncology, Department of Oncology, University of Oxford, Roosevelt Drive, Oxford, OX3 7DQ, UK.

Martin D Burkhalter (MD)

Institute of Biochemistry and Molecular Biology, Ulm University, Albert-Einstein-Allee 11, 89081, Ulm, Germany.
Department of Experimental and Clinical Pharmacology and Pharmacogenomics, University of Tübingen, 72074, Tübingen, Germany.

Marta Popović (M)

Cancer Research UK and Medical Research Council Oxford Institute for Radiation Oncology, Department of Oncology, University of Oxford, Roosevelt Drive, Oxford, OX3 7DQ, UK.
Institute Ruder Boškovic, Bijenička Cesta 54, 10000, Zagreb, Croatia.

John Fielden (J)

Cancer Research UK and Medical Research Council Oxford Institute for Radiation Oncology, Department of Oncology, University of Oxford, Roosevelt Drive, Oxford, OX3 7DQ, UK.

Bruno Vaz (B)

Cancer Research UK and Medical Research Council Oxford Institute for Radiation Oncology, Department of Oncology, University of Oxford, Roosevelt Drive, Oxford, OX3 7DQ, UK.

Judith Oehler (J)

Cancer Research UK and Medical Research Council Oxford Institute for Radiation Oncology, Department of Oncology, University of Oxford, Roosevelt Drive, Oxford, OX3 7DQ, UK.

Domenic Pilger (D)

Cancer Research UK and Medical Research Council Oxford Institute for Radiation Oncology, Department of Oncology, University of Oxford, Roosevelt Drive, Oxford, OX3 7DQ, UK.

Davor Lessel (D)

Institute of Human Genetics, University Medical Center Hamburg-Eppendorf, 20246, Hamburg, Germany.

Katherine Wiseman (K)

Cancer Research UK and Medical Research Council Oxford Institute for Radiation Oncology, Department of Oncology, University of Oxford, Roosevelt Drive, Oxford, OX3 7DQ, UK.

Abhay Narayan Singh (AN)

Cancer Research UK and Medical Research Council Oxford Institute for Radiation Oncology, Department of Oncology, University of Oxford, Roosevelt Drive, Oxford, OX3 7DQ, UK.

Iolanda Vendrell (I)

Cancer Research UK and Medical Research Council Oxford Institute for Radiation Oncology, Department of Oncology, University of Oxford, Roosevelt Drive, Oxford, OX3 7DQ, UK.
TDI Mass Spectrometry Laboratory, Target Discovery Institute, Nuffield Department of Medicine, University of Oxford, Oxford, OX3 7FZ, UK.

Roman Fischer (R)

TDI Mass Spectrometry Laboratory, Target Discovery Institute, Nuffield Department of Medicine, University of Oxford, Oxford, OX3 7FZ, UK.

Melanie Philipp (M)

Institute of Biochemistry and Molecular Biology, Ulm University, Albert-Einstein-Allee 11, 89081, Ulm, Germany.
Department of Experimental and Clinical Pharmacology and Pharmacogenomics, University of Tübingen, 72074, Tübingen, Germany.

Kristijan Ramadan (K)

Cancer Research UK and Medical Research Council Oxford Institute for Radiation Oncology, Department of Oncology, University of Oxford, Roosevelt Drive, Oxford, OX3 7DQ, UK. kristijan.ramadan@oncology.ox.ac.uk.

Articles similaires

Robotic Surgical Procedures Animals Humans Telemedicine Models, Animal

Odour generalisation and detection dog training.

Lyn Caldicott, Thomas W Pike, Helen E Zulch et al.
1.00
Animals Odorants Dogs Generalization, Psychological Smell
Animals TOR Serine-Threonine Kinases Colorectal Neoplasms Colitis Mice
Animals Tail Swine Behavior, Animal Animal Husbandry

Classifications MeSH